中药蒲公英的研究进展  

Research progress of a Chinese traditional drug taraxacum herb

作　　者：凌云[1] 郑俊华[2] 

机构地区：[1]海军总医院药剂科,北京100037 [2]北京医科大学药学院,北京100083

出　　处：《中国现代应用药学》1998年第3期10-13,共4页Chinese Journal of Modern Applied Pharmacy

摘　　要：目的:综述蒲公英的原植物、化学成分、药理作用和临床应用方面的研究进展,方法:查阅关于蒲公英的国内外文献。结果:蒲公英的化学成分研究仅见国外的Taraxacum officinale。药理作用和临床应用仅限于蒲公英的粗制剂,单一成分的药理作用缺乏。结论:应加强蒲公英的化学成分研究,阐明蒲公英中的有效成分。OBJECTIVE:To review dandelions' botanical orgin, chemical constituents,pharmacdogical activities,and clinical use.METHODE:To consult literatures at home and abroad. RESULTS:Chemical constituents were reported only in external materials, pharmacological actions and clinicel use are limited to crude preparations, effective constituents of the drug have not been knawn yet. CONCLUSION: studies on the constituents must be stemgthened, thus elucidating active constituents of the herb, guranteing its effectiveness and safety in clinical use.

关 键 词：蒲公英 化学成分 临床应用 

分 类 号：R282.71[医药卫生—中药学] R284.1[医药卫生—中医学]